Metreleptin for treating lipodystrophy

daughter started metreleptin, they had to lock cupboards because her intense hunger led her to search for food. But, since starting the treatment her hunger had reduced, and food seeking had stopped. The clinical experts agreed that metreleptin reduces hunger and food seeking. They also noted that children with congenital leptin deficiency could continue benefiting from metreleptin when having treatment for over 20 years, including avoiding obesity and related comorbidities. The committee queried whether there was any continued effect of metreleptin if patients stop the treatment. Clinical experts stated that symptoms of hyperphagia will return after a few days once metreleptin is stopped. The committee noted that, in the studies, a substantial number of patients stopped metreleptin treatment. The clinical experts explained that this could be because metreleptin only treats leptin deficiency and does not correct problems associated with loss of adipose tissue. The company explained that some patients who were seen as stopping treatment had remained on metreleptin but moved to local treatment centres where treatment was provided through compassionate use programmes. It stated that it intended to capture patient- reported outcomes, including hunger scores, as part of its post-authorisation commitments. The committee agreed that any additional information (qualitative
